BofA Reinstates Coverage On Gland Pharma, Glenmark Lifesciences With A 'Buy'; 'Neutral' On Divi's

Bank of America (BofA) Securities has reinstated coverage on certain active pharmaceutical companies and contract development and manufacturing companies in the Indian pharma industry.

Related Keywords

China , ,Divi Laboratories Ltd ,Gland Pharma Ltd ,Glenmark Lifesciences Ltd ,Bofa Securities ,Gland Pharma ,Glenmark Lifesciences ,Laboratories Ltd ,Divis Laboratories Ltd ,Glenmark Life Sciences Ltd ,Laurus Labs Ltd ,Bqmetered ,